France· FR:64450063
SMECTA 3 g FRAISE, poudre pour suspension buvable en sachet
A diosmectit product containing diosmectite, registered in France by MAYOLY PHARMA FRANCE. The same ATC class is registered in 4 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Diosmectit is registered in 4 of 19 countries.
Countries holding a registration under ATC A07BC05 (diosmectit), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 4 of them publish a price we can compare per daily dose
Diosmectit · ATC A07BC05
4 / 19 countries
- Belgiumprice
- Czechiaprice
- Franceprice
- Polandprice
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- DIOSMECTITE
- Manufacturer
- MAYOLY PHARMA FRANCE
- Country
- France (FR)
- ATC code
- A07BC05
- ATC class
- Diosmectit
- Defined daily dose
- 9 g, O
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip13340093000792118 sachet(s) papier kraft aluminium polyéthylène de 3,76 g
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Diosmectit in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Bulgaria · Смекта
- Czechia · Smecta
- Estonia · Smecta
- Greece · Smecta
- Hungary · Smecta
- Italy · Diosmectal
- Lithuania · Diosmectite Siromed, Smecta
- Latvia · Smecta
- Poland · Smecta
- Romania · Smecta
- Slovakia · Smecta
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e92a71d8-8f57-47a0-bd05-7ece4d400170 GET /v1/drugs/e92a71d8-8f57-47a0-bd05-7ece4d400170?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "64450063",
"date_amm": "2013-08-29",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "DIOSMECTITE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre pour suspension buvable",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about diosmectit.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.